When Triptolide impacts cancer cells, it interferes with the mechanisms commonly referred to as ADN432, resulting in a decrease in EZH2 (Enhancer of zeste homolog 2) mRNA, a histone methyltransferase that often contributes to gene silencing in cancer. Implications for Treatment By affecting ADN432 and reducing EZH2, the treatment:
Studies have implicated ADN432 in a range of diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. For example, research has shown that ADN432 is overexpressed in certain types of cancer, suggesting that this sequence may play a role in tumorigenesis. Additionally, ADN432 has been linked to neurodegenerative disorders such as Alzheimer's and Parkinson's disease, where it is thought to contribute to the degeneration of neurons. adn432